Rovensa Next Launches TYPHOON® and GALACTEK® in North America, Expands Biosolutions Portfolio
24 February 2026, Madrid: Rovensa Next has announced the launch of two biosolutions in the North American market, TYPHOON® and GALACTEK®. The
Read More
24 February 2026, Madrid: Rovensa Next has announced the launch of two biosolutions in the North American market, TYPHOON® and GALACTEK®. The
Read More